← FDA Warning Letters

Namita A. Goyal, M.D.

FDA Warning Letter · 2024-10-22 · Center for Biologics Evaluation and Research (CBER)

Letter

Company
Namita A. Goyal, M.D.
Posted Date
2024-10-22
Letter Issue Date
2024-10-10
Issuing Office
Center for Biologics Evaluation and Research (CBER)

Subject

Clinical Investigator

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown